false
false
false
false
false
false
false
false
false
true
false
false
false
false
false
true
false
No description of principal activity
2017-02-01
Sage Accounts Production Advanced 2018 - FRS
33,917
2,452
4,474
31,895
24,535
6,424
4,474
26,485
5,410
9,382
xbrli:pure
xbrli:shares
iso4217:GBP
03769280
2017-02-01
2018-01-31
03769280
2018-01-31
03769280
2017-01-31
03769280
2016-02-01
2017-01-31
03769280
2017-01-31
03769280
core:PlantMachinery
2017-02-01
2018-01-31
03769280
core:PlantMachinery
2017-01-31
03769280
core:PlantMachinery
2018-01-31
03769280
core:WithinOneYear
2018-01-31
03769280
core:WithinOneYear
2017-01-31
03769280
core:ShareCapital
2018-01-31
03769280
core:ShareCapital
2017-01-31
03769280
core:RetainedEarningsAccumulatedLosses
2018-01-31
03769280
core:RetainedEarningsAccumulatedLosses
2017-01-31
03769280
core:BetweenOneFiveYears
2017-01-31
03769280
core:PlantMachinery
2017-01-31
03769280
bus:Director1
2017-02-01
2018-01-31
03769280
bus:SmallEntities
2017-02-01
2018-01-31
03769280
bus:Audited
2017-02-01
2018-01-31
03769280
bus:FullAccounts
2017-02-01
2018-01-31
03769280
bus:SmallCompaniesRegimeForAccounts
2017-02-01
2018-01-31
03769280
bus:PrivateLimitedCompanyLtd
2017-02-01
2018-01-31
COMPANY REGISTRATION NUMBER:
03769280
AMS Advanced Medical Services Limited
|
|
Filleted Financial Statements
|
|
AMS Advanced Medical Services Limited
|
|
Year ended 31 January 2018
Statement of financial position
|
1
|
|
|
Notes to the financial statements
|
2
|
|
|
AMS Advanced Medical Services Limited
|
|
Statement of Financial Position
|
|
31 January 2018
Fixed assets
Tangible assets
|
5
|
|
5,410
|
9,382
|
|
|
|
|
|
Current assets
Debtors
|
6
|
1,407,712
|
|
878,682
|
Cash at bank and in hand
|
1,157,113
|
|
602,589
|
|
------------
|
|
------------
|
|
2,564,825
|
|
1,481,271
|
|
|
|
|
|
Creditors: amounts falling due within one year
|
7
|
945,447
|
|
633,506
|
|
------------
|
|
------------
|
Net current assets
|
|
1,619,378
|
847,765
|
|
|
------------
|
---------
|
Total assets less current liabilities
|
|
1,624,788
|
857,147
|
|
|
|
|
|
Provisions
Taxation including deferred tax
|
|
805
|
1,591
|
|
|
------------
|
---------
|
Net assets
|
|
1,623,983
|
855,556
|
|
|
------------
|
---------
|
|
|
|
|
Capital and reserves
Called up share capital
|
|
50,000
|
50,000
|
Profit and loss account
|
|
1,573,983
|
805,556
|
|
|
------------
|
---------
|
Shareholders funds
|
|
1,623,983
|
855,556
|
|
|
------------
|
---------
|
|
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the
board of directors
and authorised for issue on
31 July 2018
, and are signed on behalf of the board by:
K L Hutchinson
Director
Company registration number:
03769280
AMS Advanced Medical Services Limited
|
|
Notes to the Financial Statements
|
|
Year ended 31 January 2018
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 22 Friars Street, Sudbury, Suffolk, CO10 2AA. The business address is 26-28 Hammersmith Grove, London, W6 7BA.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
Equipment
|
-
|
33% straight line
|
|
|
|
|
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4.
Particulars of employees
The average number of persons employed by the company during the year amounted to
7
(2017:
7
).
5.
Tangible assets
|
Plant and machinery
|
Total
|
|
£
|
£
|
Cost
|
|
|
At 1 February 2017
|
33,917
|
33,917
|
Additions
|
2,452
|
2,452
|
Disposals
|
(
4,474)
|
(
4,474)
|
|
--------
|
--------
|
At 31 January 2018
|
31,895
|
31,895
|
|
--------
|
--------
|
Depreciation
|
|
|
At 1 February 2017
|
24,535
|
24,535
|
Charge for the year
|
6,424
|
6,424
|
Disposals
|
(
4,474)
|
(
4,474)
|
|
--------
|
--------
|
At 31 January 2018
|
26,485
|
26,485
|
|
--------
|
--------
|
Carrying amount
|
|
|
At 31 January 2018
|
5,410
|
5,410
|
|
--------
|
--------
|
At 31 January 2017
|
9,382
|
9,382
|
|
--------
|
--------
|
|
|
|
6.
Debtors
|
2018
|
2017
|
|
£
|
£
|
Trade debtors
|
1,171,488
|
720,206
|
Other debtors
|
236,224
|
158,476
|
|
------------
|
---------
|
|
1,407,712
|
878,682
|
|
------------
|
---------
|
|
|
|
7.
Creditors:
amounts falling due within one year
|
2018
|
2017
|
|
£
|
£
|
Trade creditors
|
181,655
|
62,846
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest
|
394,549
|
398,210
|
Corporation tax
|
182,765
|
123,346
|
Social security and other taxes
|
26,974
|
27,720
|
Other creditors
|
159,504
|
21,384
|
|
---------
|
---------
|
|
945,447
|
633,506
|
|
---------
|
---------
|
|
|
|
8.
Commitments under operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
|
2018
|
2017
|
|
£
|
£
|
Not later than 1 year
|
–
|
132,851
|
Later than 1 year and not later than 5 years
|
–
|
98,791
|
|
----
|
---------
|
|
–
|
231,642
|
|
----
|
---------
|
|
|
|
9.
Summary audit opinion
The auditor's report for the year dated 31 July 2018 was unqualified.
The senior statutory auditor was
Matthew Wilkinson BSc FCA
, for and on behalf of
Moore Green
.
10.
Related party transactions
During the year the company paid interest of £6,015 (2017: £2,907) on loans from it's parent company. Additional capital, if required, is provided by advances from the holding company via an inter-company loan account. Such advances are generally short term and often in connection with, or settled by, charges for work done for, and expenses incurred on behalf of the holding company. Included within current liabilities at the end of the year is an amount of £398,170 (last- £198,210) in respect of these transactions. Purchases and sales totalling £967,295 and £306,343 respectively were made with the holding company during the year. During the year consultancy fees totalling £24,000 (2017: £24,000) plus expenses of £940 (2017: £1,342) were charged to the company by D George, a non-executive director.
11.
Controlling party
AMS Advanced Medical Services GmbH is the ultimate parent company, owning 100% of the allotted and fully paid share capital of the company. Christian Carls, a director of the company, has the controlling interest in the issued share capital of the ultimate parent company.